FDA RAISES FINANCIAL DISCLOSURE THRESHOLD OF PAYMENTS TO INVESTIGATORS TO $25,000; LESS THAN 10% OF ALL APPLICATIONS WILL NEED DISCLOSURE, AGENCY PREDICTS
Executive Summary
FDA has raised the threshold for disclosure of payments to investigators by study sponsors from $5,000 to $25,000 in the agency's final rule on financial disclosures by clinical investigators. The rule was published in the Feb. 2 Federal Register.